May 13, 2025 / 12:00PM GMT
Operator
Good morning and welcome to Y-mAbs Therapeutics first-quarter 2025 earnings conference call.
(Operator Instructions)
As a reminder, today's conference will be recorded.
I would now like to hand the call over to Y-mAbs' Head of IR, Courtney Dugan. Please go ahead.
Courtney Dugan - Y-mAbs Therapeutics Inc - Vice President, Head, Investor Relations
Thank you, operator, and good morning, everyone.
Welcome to the Y-mAbs first-quarter 2025 financial results conference call. We issued a press release with our results this morning before the market opened. The press release and accompanying slides are available on the IR section of our website.
Let me quickly remind you that the following discussion contains certain statements that are considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements include but are not limited to statements about our business model, commercialization and product distribution plans, expectations with respect to our business
Q1 2025 Y-mAbs Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
